Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a singleinstitution study of 1343 Chinese patients

Annals of Oncology

Volumn 22, Issue 9, 2011, Pages 2049-2056

  Wang, W ^a   Xu, D Z ^a   Li, Y F ^a   Guan, Y X ^a   Sun, X W ^a   Chen, Y B ^a   Kesari, R ^a   Huang, C Y ^a   Li, W ^a   Zhan, Y Q ^a   Zhou, Z W ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

China; Gastric cancer; Lymph node ratio; Prognosis; UICC TNM system 7th edition

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR RATIO METASTASIS STAGING; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80052422756     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq716     Document Type: Article

References (35)

1. Garcia M, Jemal A et al. Global Cancer Facts and Figures 2007. 2007.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
3. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th edition. 2010.
4. Deng J, Liang H, Sun D et al. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol 2010; 17: 1259-1266.
5. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 14th edition. In Edition 2010; 17.
6. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-1608.
7. Aurello P, D'Angelo F, Rossi S et al. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg 2007; 73: 359-366.
8. Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 2006; 107: 2143-2151.
9. Ichikawa D, Kurioka H, Ueshima Y et al. Prognostic value of lymph node staging in gastric cancer. Hepatogastroenterology 2003; 50: 301-304.
10. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edition. 2002.
11. Bando E, Yonemura Y, Taniguchi K et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002; 9: 775-784.
12. Inoue K, Nakane Y, Iiyama H et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002; 9: 27-34.
13. Nitti D, Marchet A, Olivieri M et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003; 10: 1077-1085.
14. Rodriguez Santiago JM, Munoz E, Marti M et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol 2005; 31: 59-66.
15. Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol 2007; 96: 95-101.
16. Saito H, Fukumoto Y, Osaki T et al. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 2008; 97: 132-135.
17. Marchet A, Mocellin S, Ambrosi A et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007; 245: 543-552.
18. Sun Z, Zhu GL, Lu C et al. The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol 2009; 20: 897-905.
19. Kulig J, Sierzega M, Kolodziejczyk P, Popiela T. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 2009; 96: 910-918.
20. Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C et al. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol 2010; 17: 1267-1277.
21. Xu DZ, Geng QR, Long ZJ et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 2009; 16: 319-326.
22. Kim CY, Yang DH. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol 2009; 16: 1868-1874.
23. Deng J, Liang H, Wang D et al. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol 2010; 17: 1043-1051.
24. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1998; 1: 10-24.
25. Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10: 7252-7259.
26. Harrell FE Jr, Califf RM, Pryor DB et al. Evaluating the yield of medical tests. JAMA 1982; 247: 2543-2546.
27. Cho YK, Chung JW, Kim JK et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer 2008; 112: 352-361.
28. Kee KM, Wang JH, Lee CM et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 2007; 120: 2650-2655.
29. Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 2000; 88: 2721-2730.
30. Hsu PK, Wu YC, Chou TY et al. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg 2010; 89: 1024-1031.
31. Hollander N, Schumacher M. On the problem of using 'optimal' cutpoints in the assessment of quantitative prognostic factors. Onkologie 2001; 24: 194-199.
32. Fedorov V, Mannino F, Zhang R. Consequences of dichotomization. Pharm Stat 2009; 8: 50-61.
33. Austin PC, Brunner LJ. Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses. Stat Med 2004; 23: 1159-1178.
34. Schmoor C, Schumacher M. Effects of covariate omission and categorization when analysing randomized trials with the Cox model. Stat Med 1997; 16: 225-237.
35. Ueno S, Tanabe G, Sako K et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 529-534.